Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?

BACKGROUND: Rifamycins are a group of antibiotics mainly used in the treatment of tuberculosis (TB), however they interact with antiretroviral therapy (ART). Rifabutin allows more regimens options for concomitant imunodeficiency virus (HIV) treatment compared to rifampicin. OBJECTIVE: Compare the ou...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mem Inst Oswaldo Cruz
Hlavní autoři: Schmaltz, Carolina Arana Stanis, Demitto, Fernanda de Oliveira, Sant’Anna, Flavia Marinho, Rolla, Valeria Cavalcanti
Médium: Artigo
Jazyk:Inglês
Vydáno: Instituto Oswaldo Cruz, Ministério da Saúde 2019
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6372173/
https://ncbi.nlm.nih.gov/pubmed/30758392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/0074-02760180420
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky